Clinical effectiveness of fixed-dose combination of perindopril, indapamide and amlodipine in patients with arterial hypertension and abdominal obesity. Results of 12-week observation

S.M. Koval, T.H. Strashnenko, M.Yu. Penkova, O.V. Mysnychenko, K.O. Yushko, O.M. Lytvynova

Abstract


Background. Treatment of hypertension in patients with abdominal obesity is a very difficult task. Therefore, combined antihypertensive therapy with the use of two or more components is the most appropriate. The aim of the work was to study the clinical efficacy of a fixed-dose combination of perindopril, indapamide and amlodipine in patients with hypertension and abdominal obesity. Materials and methods. The study included 32 patients with uncontrolled essential hypertension and abdominal obesity before and after 12 weeks of using perindopril/indapamide/amlodipine fixed-dose triple combination on the background of atorvastatin therapy and dietary recommendations. Results. It is shown that the use of perindopril/indapamide/amlodipine fixed-dose triple combination together with moderate doses of statins and dietary recommendations in patients with uncontrolled essential hypertension and abdominal obesity leads to the positive changes in blood lipid levels and does not cause deterioration in the metabolism of carbohydrates and purines. Conclusions. High efficacy of the approved fixed-dose triple combination of antihypertensive drugs was established in this cohort of patients.


Keywords


hypertension; abdominal obesity; antihypertensive therapy; fixed-dose triple combination of antihypertensive drugs

References


Беловол А.Н., Школьник В.В., Фадеенко Г.Д., Тверетинов А.Б. Гипертоническая болезнь и ожирение: Монография. — Тернополь: ТГМУ, 2013. — 344 с.

Мітченко О.І., Лаврик А.С., Романов В.Ю., Чулаєвська І.В., Шкрьоба А.О. Чинники серцево-судинного ризику у хворих з морбідним ожирінням та шляхи їх медикаментозної, немедикаментозної і хірургічної корекції // Серце і судини. — 2013. — № 2. — С. 98-105.

Настанова з артеріальної гіпертензії / За ред.В.М. Коваленка, Є.П. Свіщенко, Ю. Сіренка. — Київ, 2010. — 492 с.

Фадеенко Г.Д. Ожирение и риск сердечно-сосудистых заболеваний // Ліки України. — 2009. — № 7(133). — С. 55-64.

Kilpelainen K., Tuomi-Nikula A. et al. Health indicators in the Europe: availability and data needs // Eur. J. Public Health. — 2012. — V. 22. — № 5. — Р. 716-721.

Chobanian A.V., Bakris G.L., Black H.R. et al. The se-venth report of the Joint National Committee on prevention, detection, evalution, and treatment of high blood pressure: the JNC 7 report // JAMA. — 2003. — V. 289. — P. 2560-2572.

2013 ESH/ESC Guidelines for management of arterial hypertension // J. of Hypertension. — 2013. — № 31. — 1357 p.

Burnier M., Wuerzner G., Waeber B. Medical treatment of hypertension: monotherapy and combination therapy // Manual of hypertension of the European Society of Hypertension / Ed. by G. Mancia, G. Grassi and J. Redon. — 2014. — P. 309-318.

Dahlof B., Sever P.S., Poulter N.R. et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumetiazide as required in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial // Lancet. — 2005. — V. 366. — P. 895-906.

Mourad J.J., Amodeo C., de Champvallins M., Brzozowska-Villatte R., Asmar R. Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial // J. Hypertens. — 2017. — V. 35(7). — P. 1481-1495.

Mazza A., Lenti S., Schiavon L., Sacco A.P., Dell’Avvocata F., Rigatelli G., Ramazzina E. Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice // Adv. Ther. — 2017. — V. 34(4). — P. 975-985.

Tóth K. PIANIST Investigators. Antihypertensive efficacy of triple combination perindopril/indapamide plus amlodipine in high-risk hypertensives: results of the PIANIST study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients) // Am. J. Cardiovasc. Drugs. — 2014. — V. 14(2). — P. 137-145.

Настанова та клінічний протокол надання медичної допомоги «Артеріальна гіпертензія»: Наказ МОЗ України

№ 384 від 24.05.2012 р. — Київ, 2012. — 106 с.

Lang R.M., Bierig, Richard M., Devereux B. Recommendations for сhamber guantification. // Eur. J. Echocardioography. — 2006. — Vol. 7. — P. 78-108.

Osterberg L., Blaschke T. Adherence to medication // N. Engl. J. Med. — 2005. — V. 353. — P. 487-497.




DOI: https://doi.org/10.22141/2224-1485.5.55.2017.115338

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 HYPERTENSION

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2018

 

   Seo анализ сайта